These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35961489)

  • 21. Factors associated with not receiving the primary series and booster dose of the COVID-19 vaccine among Venezuelan migrants in Peru: A population-based cross-sectional study.
    Al-Kassab-Córdova A; Silva-Perez C; Mendez-Guerra C; Herrera-Añazco P; Benites-Zapata VA
    Travel Med Infect Dis; 2023; 53():102563. PubMed ID: 36898490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV and COVID-19 in Latin America and the Caribbean.
    Garcia PJ; Cabrera DM; Cárcamo PM; Diaz MM
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):37-45. PubMed ID: 35092570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
    Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
    Front Public Health; 2022; 10():846861. PubMed ID: 35462827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with intention to be vaccinated with the COVID-19 booster dose: a cross-sectional study in Peru.
    Camacho-Neciosup R; Balcazar-Huaman EN; Alvarez-Vilchez ML; De la Cruz-Galán JP; Gálvez-Guadalupe Y; Garcia-Muñoz ED; Cerron-Daga G; Failoc-Rojas VE; Valladares-Garrido MJ
    PeerJ; 2024; 12():e16727. PubMed ID: 38563006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of Environmental risks and vulnerability factors of indigenous populations from Latin America and the Caribbean in the face of the COVID-19.
    Flores-Ramírez R; Berumen-Rodríguez AA; Martínez-Castillo MA; Alcántara-Quintana LE; Díaz-Barriga F; Díaz de León-Martínez L
    Glob Public Health; 2021 Jul; 16(7):975-999. PubMed ID: 33966608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
    McConeghy KW; White EM; Blackman C; Santostefano CM; Lee Y; Rudolph JL; Canaday D; Zullo AR; Jernigan JA; Pilishvili T; Mor V; Gravenstein S
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(39):1235-1238. PubMed ID: 36173757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boosters and time from the last anti-COVID-19 vaccine dose: lead public health choices by real-time epidemiological assessment.
    Russo AG; Murtas R; Tunesi S; Decarli A; Bergamaschi W
    Epidemiol Prev; 2022; 46(1-2):34-46. PubMed ID: 35354266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months.
    Low EV; Tok PSK; Husin M; Suah JL; Tng BH; Thevananthan T; Appannan MR; Yahaya H; Mohd Zin S; Muhamad Zin F; Sivasampu S; Peariasamy KM
    JAMA Netw Open; 2022 Aug; 5(8):e2226046. PubMed ID: 35947381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022.
    Lu PJ; Srivastav A; Vashist K; Black CL; Kriss JL; Hung MC; Meng L; Zhou T; Yankey D; Masters NB; Fast HE; Razzaghi H; Singleton JA
    Emerg Infect Dis; 2023 Jan; 29(1):133-140. PubMed ID: 36480674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 vaccine uptake among people with HIV: identifying characteristics associated with vaccine hesitancy.
    Boschung K; Gill MJ; Krentz HB; Dalere J; Beckthold B; Fonseca K; Bakal JA; McMillan JM; Kanji J; Lang R
    Sci Rep; 2023 Nov; 13(1):20610. PubMed ID: 37996521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consumption of Herbal Supplements or Homeopathic Remedies to Prevent COVID-19 and Intention of Vaccination for COVID-19 in Latin America and the Caribbean.
    Bendezu-Quispe G; Benites-Meza JK; Urrunaga-Pastor D; Herrera-Añazco P; Uyen-Cateriano A; Rodriguez-Morales AJ; Toro-Huamanchumo CJ; Hernandez AV; Benites-Zapata VA
    Trop Med Infect Dis; 2022 Jun; 7(6):. PubMed ID: 35736974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 vaccination process in Latin America and the Caribbean.
    Caycho-Rodríguez T; Gallegos M; White M
    Enferm Clin (Engl Ed); 2023; 33(1):72-73. PubMed ID: 36309198
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years.
    Arbel R; Sergienko R; Friger M; Peretz A; Beckenstein T; Yaron S; Netzer D; Hammerman A
    Nat Med; 2022 Jul; 28(7):1486-1490. PubMed ID: 35468276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of COVID-19 Booster Dose among Saudi Arabian Population.
    Alshahrani NZ; Alsabaani AA; Ridda I; Rashid H; Alzahrani F; Almutairi TH; Alzahrani BAS; Albeshri ASS
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888690
    [No Abstract]   [Full Text] [Related]  

  • 40. What is associated with the increased frequency of heavy episodic drinking during the COVID-19 pandemic? Data from the PAHO regional web-based survey.
    Valente JY; Sohi I; Garcia-Cerde R; Monteiro MG; Sanchez ZM
    Drug Alcohol Depend; 2021 Apr; 221():108621. PubMed ID: 33636598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.